RSV (Respiratory Syncytial Virus) is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. RSV is the #1 reason for a child under the age of 1 to be hospitalized.
Keystone Health is pleased to offer a new medication to help prevent severe RSV disease, a monoclonal antibody called nirsevimab (Beyfortus™). This is not a vaccine. It is an antibody that provides immediate protection and lasts six months, enough to get your child through the RSV season (typically the fall and winter months). The antibody is given as an injection.
This medication is recommended for all children, including newborns, up until they are 8 months of age. Certain high risk infants 8-19 months of age are also eligible for this treatment. If you would like your child to receive this, please call your child’s primary care office to schedule an appointment before they turn 8 months old. If your child is 6 months or older, ask about your child receiving their flu vaccination at the same appointment.
If you have any questions about RSV or the monoclonal antibody medication, please call your child’s primary care office at Keystone Pediatrics Chambersburg (717-709-7950), Keystone Pediatrics Waynesboro (717-387-8060), or Keystone Family Medicine (717-709-7999).
